Outcomes between PE-only and DVT-only cohorts
After propensity matching, there was no substantial difference in the baseline characteristics between the PE-only and DVT-only cohorts (Supplemental table 3). Clinical outcomes between PE-only and DVT-only cohorts were shown in Supplemental table 8. The arterial thromboembolic event was lower in the PE-only cohort than in the DVT-only cohort (SHR, 0.80; 95% CI, 0.73–0.88) (Figure 5A). The risks of ischemic stroke (SHR, 0.82; 95% CI, 0.74–0.92) and ECATE, including lower extremity events, (SHR, 0.69; 95% CI, 0.58–0.82) were lower in the PE-only cohort than in the DVT-only cohort (Figure 5B and Figure 5C). The risks of all-cause mortality (HR, 1.08; 95% CI, 1.03–1.13) and CV death (HR, 1.28; 95% CI, 1.19–1.37) were higher in the PE-only cohort compared to the DVT-only cohort (Figure 5D and Figure 5E).